Enumeral Biomedical (ENUM) 10-Q2016 Q1 Quarterly report

Filed: 13 May 16, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Bad

New words: accelerated, ACS, ago, alter, alternative, Anderson, announced, antagonist, arithmetic, array, ASC, assumption, bankruptcy, began, binding, biological, biopharmaceutical, biopsy, blank, blended, calendar, century, certificate, check, Code, commensurate, complementary, compute, concept, conservation, contemplate, curtail, daily, Deferral, display, distinction, distinctly, diversity, downsize, effector, elicited, enacted, ENUM, equivalent, expertise, exploring, extension, face, factor, family, field, forfeiture, Fountain, fourth, fundamentally, fusion, GmbH, guide, harm, high, implement, implementation, IMR, infiltrating, infrastructure, inhibit, input, Investigational, ipilimumab, January, Keytruda, lab, lack, lessee, lessor, ligand, listed, live, LP, lung, master, MDACC, microwell, multidimensional, multipurpose, multispecific, nivolumab, Opdivo, opposed, ownership, par, partially, pembrolizumab, principle, produce, promptly, protein, pursuing, range, ranging, rapid, recovery, resolution, SBIR, secreted, selected, selection, selectivity, settle, similarly, simply, situated, slightly, statutory, stimulating, stratification, structure, taxable, technical, tool, transition, type, undisclosed, valuable, vi, Whitehead, wind, withholding, Yervoy

Removed: acceptance, aggregated, anticipated, area, arisen, Barry, breadth, build, burn, characterize, checkpoint, combination, compensated, complex, compliance, comply, component, comprise, consistent, continuing, coupled, deadline, deficiency, dependence, destruction, disclose, discontinue, effected, elucidate, emerging, enable, enter, entering, establish, evade, evaluation, evasion, executed, execution, extended, extinguishment, flow, grow, half, hiring, improve, inform, initially, Internet, interrogate, investor, itinerary, joint, key, laboratory, life, likelihood, lymphocyte, member, microenvironment, modulation, monthly, obtain, October, opportunity, optimal, partnered, payroll, person, personnel, power, precise, prolonged, promissory, rare, recent, repaid, requirement, resistance, retention, role, schedule, screening, seek, serve, singly, site, stage, stand, standalone, stated, studying, subset, superior, survival, targeted, technological, temporary, testing, TIL, trailing, translational, treating, trip, uncertainty, understand, unique, unrestricted, validation, verifiable, vested, vivo, website, weight, yield

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

ENUM similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Enumeral Biomedical Holdings, Inc. (the “Company”) for the quarter ended March 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Arthur H. Tinkelenberg, Ph.D., Chief Executive Officer and President of the Company, hereby certifies, pursuant to Rule 13a-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: May 13, 2016	/s/ Arthur H. Tinkelenberg, Ph.D.
	Arthur H. Tinkelenberg, Ph.D.
	Chief Executive Officer and President
	(Principal Executive Officer)